China Transmucosal Drug Delivery Systems Market

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Analysis and Forecasts by Route of Administration (Oral, Vaginal, Nasal, Urethral/Rectal); Age Group (Adults, Pediatrics); End User (Hospitals, Clinics, Others)

No. of Pages: 70
Report Code: TIPRE00006570
Category: Life Sciences
China Transmucosal Drug Delivery Systems Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. China Transmucosal Drug Delivery Systems Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. China Transmucosal Drug Delivery Systems Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. China Transmucosal Drug Delivery Systems Market Country Analysis

6.2 China Transmucosal Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)
6.3 China Transmucosal Drug Delivery Systems Market Forecast Analysis

7. China Transmucosal Drug Delivery Systems Market Analysis – by Route of Administration

7.1 Oral
  • 7.1.1 Overview
  • 7.1.2 Oral: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Vaginal
  • 7.2.1 Overview
  • 7.2.2 Vaginal: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.3 Nasal
  • 7.3.1 Overview
  • 7.3.2 Nasal: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.4 Urethral/Rectal
  • 7.4.1 Overview
  • 7.4.2 Urethral/Rectal: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. China Transmucosal Drug Delivery Systems Market Analysis – by Age Group

8.1 Adults
  • 8.1.1 Overview
  • 8.1.2 Adults: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Pediatrics
  • 8.2.1 Overview
  • 8.2.2 Pediatrics: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. China Transmucosal Drug Delivery Systems Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Clinics: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. China Transmucosal Drug Delivery Systems Market – China Analysis

10.1 China
  • 10.1.1 China: China Transmucosal Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1 China: China Transmucosal Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.2 China: China Transmucosal Drug Delivery Systems Market Breakdown, by Age Group
    • 10.1.1.3 China: China Transmucosal Drug Delivery Systems Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 3M
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Acrux Limited
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 GW Pharmaceuticals plc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 INTELGENX CORP
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Mylan N.V.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Novartis AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Reckitt Benckiser Group plc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 UCB S.A.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 West Pharmaceutical Development, LLC
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - China Transmucosal Drug Delivery Systems Market

  • 3M
  • Acrux Limited
  • GW Pharmaceuticals plc
  • INTELGENX CORP
  • Mylan N.V.
  • Novartis AG
  • Reckitt Benckiser Group plc.
  • Teva Pharmaceutical Industries Ltd
  • UCB S.A.
  • West Pharmaceutical Development, LLC

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)